MedTrace Logo

Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer

NCT02306096 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2024-02-09

No results posted yet for this study

Summary

This study evaluates the genomic profiles of breast cancer in a prospective and population-based manner. In the first phase, breast tumors are analyzed by whole transcriptome RNA-sequencing. Gene expression profiles, mutational profiles, and transcript isoform-level data will be analyzed in the context of patient information, clinicopathological variables, and outcome, with the purpose to develop new molecular diagnostic assays for breast cancer. Additional genome-scale RNA, DNA, and protein analyses will be performed in the future.

Conditions

  • Breast Neoplasms

Sponsors & Collaborators

  • South Sweden Breast Cancer Group

    collaborator UNKNOWN

  • Mrs. Berta Kamprad Foundation

    collaborator UNKNOWN

  • U-CAN

    collaborator UNKNOWN

  • Lund University

    lead OTHER

Principal Investigators

  • Åke Borg, PhD · Lund University

  • Cecilia Hegardt, PhD · Lund University

  • Christer Larsson, PhD · Lund University

  • Niklas Loman, MD, PhD · Skane University Hospital

  • Johan Vallon-Christersson, PhD · Lund University

  • Anna Ehinger, MD, PhD · Skane University Hospital

  • Lisa Rydén, MD, PhD · Skane University Hospital

  • Lao H Saal, MD, PhD · Lund University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2031-08-31
Completion
2031-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02306096 on ClinicalTrials.gov